ArticleFrontiers in immunology2026

CDK4/6 inhibition with dual immunotherapy in chemorefractory SMARCA4-deficient undifferentiated tumor: a case report.

Ünal Metin Tokat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.